Cognitive impairments in multiple sclerosis: a review (Q30671631)

26 June 2017

1 reference

title

Cognitive impairments in multiple sclerosis: a review (English)

1 reference

26 June 2017

0 references

cognitive dysfunction

1 reference

based on heuristic

inferred from title

author name string

Eduardo Adonias DeSousa

series ordinal

1

1 reference

26 June 2017

Ross H Albert

series ordinal

2

1 reference

26 June 2017

Bernadette Kalman

series ordinal

3

1 reference

26 June 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

American Journal of Alzheimer's Disease & Other Dementias

26 June 2017

published in

1 reference

26 June 2017

volume

17

1 reference

26 June 2017

issue

1

1 reference

26 June 2017

page(s)

23-29

1 reference

Identifying multiple sclerosis patients with mild or global cognitive impairment using the Screening Examination for Cognitive Impairment (SEFCI).

26 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

Defining the clinical course of multiple sclerosis: Results of an international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

Fluid-attenuated inversion recovery magnetic resonance imaging detects cortical and juxtacortical multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

Pathologic damage in MS assessed by diffusion-weighted and magnetization transfer MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

A serial study of new MS lesions and the white matter from which they arise

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

Imaging axonal damage of normal-appearing white matter in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

Does the extent of axonal loss and demyelination from chronic lesions in multiple sclerosis correlate with the clinical subgroup?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

Spectrum and classification of inflammatory demyelinating diseases of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

The genetics of multiple sclerosis: principles, background and updated results of the United Kingdom systematic genome screen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

The Brief Repeatable Battery of Neuropsychological Tests for Multiple Sclerosis: a preliminary serial study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

Neuropsychological deficits in multiple sclerosis after acute relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

Brain magnetic resonance imaging correlates of cognitive impairment in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

SPECT, MRI and cognitive functions in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

Magnetic resonance imaging correlates of dementia in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

Neuropsychological and structural brain lesions in multiple sclerosis: A regional analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

Relationship between frontal lobe lesions and Wisconsin Card Sorting Test performance in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

Assessment of the damage of the cerebral hemispheres in MS using neuroimaging techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

Patterns of cognitive impairment in secondary progressive stable phase of multiple sclerosis: correlations with MRI findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

Clinical significance of reduced cerebral metabolism in multiple sclerosis: a combined PET and MRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

Cause of death in patients attending multiple sclerosis clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

Cognitive functioning and depression in patients with chronic fatigue syndrome and multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

Correlates of cognitive impairment and depressive mood disorder in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

A full genome search in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

Genomewide scan of multiple sclerosis in Finnish multiplex families

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

Apoliprotein E and multiple sclerosis: impact of the epsilon-4 allele on susceptibility, clinical type and progression rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

APOE genotype is a major predictor of long-term progression of disability in MS

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

A longitudinal study of brain atrophy in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

Neuropsychologic status in multiple sclerosis after treatment with glatiramer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

Interferon beta 1-b in verbal memory functioning of patients with relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

A 12-week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairments

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153331750201700104

10.1177/153331750201700104

21 January 2018

Identifiers

DOI

1 reference

26 June 2017

1 reference